Completed
Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Adult (18-40 Years Old)
NCT01123941
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Enterobacteriaceae Infections, +4 more
- Locations
-
- Center for the Evaluation of Vaccination (CEV) Antwerp, Wilrijk (Antwerp), Belgium